ResMed Inc. (ResMed) develops, manufactures and distributes of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Sleep-disordered breathing (SDB), includes obstructive sleep apnea (OSA), and other respiratory disorders that occur during sleep. It has developed a number of products for SDB and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories. 

Type
Public
HQ
San Diego, US
Founded
1989
Size (employees)
6,080 (est)
Website
resmed.com
ResMed was founded in 1989 and is headquartered in San Diego, US
Report incorrect company information

Key People/Management at ResMed

Michael Farrell

Michael Farrell

Chief Executive Officer
Rob Douglas

Rob Douglas

President and Chief Operating Officer
David Pendarvis

David Pendarvis

Chief Administrative Officer, Global General Counsel
Jim Hollingshead

Jim Hollingshead

President, Sleep Business
Richie McHale

Richie McHale

President, Respiratory Care Business
Raj Sodhi

Raj Sodhi

President, SaaS Business
Show more

ResMed Office Locations

ResMed has offices in Singapore, Kontich, Moissy-Cramayel, Planegg and in 24 other locations
San Diego, US (HQ)
9001 Spectrum Center Blvd
Rochester, US
1200 Brooks Ave
Bella Vista, AU
1 Elizabeth Macarthur Dr
Kontich, BE
50 Grote Steenweg
Beijing, CN
24 Dong San Huan Zhong Lu
Guangzhou Shi, CN
Jian She Liu Ma Lu
Show all (28)
Report incorrect company information

ResMed Financials and Metrics

ResMed Financials

ResMed's revenue was reported to be $1.84 b in FY, 2016 which is a 9.5% increase from the previous period.
USD

Revenue (Q3, 2018)

1.7 b

Gross profit (Q3, 2018)

999.7 m

Gross profit margin (Q3, 2018), %

58.2%

Net income (Q3, 2018)

205.8 m

EBIT (Q3, 2018)

394.9 m

Market capitalization (23-May-2018)

14.7 b

Closing share price (23-May-2018)

102.7

Cash (31-Mar-2018)

704.3 m

EV

14.8 b
ResMed's current market capitalization is $14.7 b.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

1.6 b1.7 b1.8 b

Revenue growth, %

8%10%

Cost of goods sold

667.5 m772.2 m

Gross profit

1 b1.1 b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

380.4 m423 m422.5 m411.6 m454.5 m453.9 m465.5 m530.4 m514.2 m523.7 m1.1 b1.7 b

Cost of goods sold

143.1 m159.7 m171.1 m173 m188 m194 m196.3 m221.3 m214.5 m218.1 m469.5 m716.9 m

Gross profit

237.3 m263.2 m251.4 m238.6 m266.5 m259.9 m269.2 m309.1 m299.7 m305.6 m655.4 m999.7 m

Gross profit Margin, %

62%62%60%58%59%57%58%58%58%58%58%58%
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

905.7 m717.2 m731.4 m

Inventories

165.4 m246.9 m224.5 m

Current Assets

1.6 b1.4 b1.4 b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

976.6 m972.7 m938.6 m881.7 m880.7 m866.3 m822.1 m658.8 m718.5 m781.7 m788.1 m827.3 m811.1 m858.9 m704.3 m

Inventories

175.4 m178.1 m164.9 m197.2 m218.1 m225.2 m258.6 m237.5 m232.9 m253.8 m253.1 m259.9 m300.5 m296.1 m288.7 m

Current Assets

1.6 b1.6 b1.6 b1.5 b1.6 b1.6 b1.5 b1.4 b1.4 b1.5 b1.5 b1.6 b1.7 b1.8 b1.6 b

PP&E

416.7 m414.3 m429 m419.8 m408.2 m384.2 m369 m375.2 m386.8 m390.8 m375.9 m387.4 m400.8 m401.5 m398 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

345.3 m352.9 m352.4 m

Depreciation and Amortization

73.5 m73.1 m86.8 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018Q3, 2018

Net Income

80.9 m167.6 m257.5 m83.3 m91.2 m91 m80.4 m90.5 m88.5 m76.1 m76.7 m87.8 m95.7 m205.8 m

Depreciation and Amortization

17.9 m36.5 m53.6 m18.4 m58.9 m88.3 m

Inventories

197.2 m218.1 m225.2 m237.5 m232.9 m253.8 m253.1 m259.9 m(20.8 m)(11.1 m)

Accounts Payable

76.2 m80 m70.9 m67.6 m77.6 m80.5 m94.1 m82.8 m
USDY, 2018

EV/EBIT

37.4 x

EV/CFO

39.3 x

Financial Leverage

1.7 x
Show all financial metrics
Report incorrect company information

ResMed News and Updates

High-flow Nasal Cannula Market: Rising Respiratory Diseases Bolster Demand

High-flow Nasal Cannula Market report categorizes the global market by Component (Oxygen Blender, Single Heated Tube & Nasal Cannulas), Application (Acute Respiratory Failure, COPD, Sleep Apnea, Bronchiectasis), End-user & Geography Posted via Industry Today. Follow us on Twitter @IndustryTo…

Orthopedic Implant Market 2018 Top Leading Players: Auxein, Orthoimplantcompany OIC, Biotek, Maxx Medical, Image ortho surgical Pvt.Ltd, etc. and Future Prospects up to 2027

Orthopedic Implant Market Set for Rapid Growth and Trend till 2027; By End Users( Hospitals, Clinics, Home care) By Types (Pins, Rods, Screws) By Applications(Hip replacement , Spine Fracture, Neck Fracture, Shoulder replacement ) and it is also cover the Market Synopsis, Segments, Regional Analysis…

Respiratory Care Devices Market 2018 : Manufacturers Analysis,Applications,Demand by Regions & Forecasts to 2023

WiseGuyReports.Com Publish a New Market Research Report On –“ Respiratory Care Devices Market 2018 : Manufacturers Analysis,Applications,Demand by Regions & Forecasts to 2023”. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information